L-Tryptophan ethyl ester dilates small mesenteric arteries by inhibition of voltage-operated calcium channels in smooth muscle

British Journal of Pharmacology

Volumn 166, Issue 1, 2012, Pages 232-242

  Jadhav, Ashok ^a   Liang, Wenbin ^b   Balsevich, John ^c   Bastin, Guillaume ^b   Kroetsch, Jeff ^b   Heximer, Scott ^b   Backx, Peter H ^b   Gopalakrishnan, Venkat ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

aorta; Ba 2+ current; blood pressure; L tryptophan; L tryptophan ethyl ester; mesenteric artery; phenylephrine; potassium chloride; voltage operated Ca 2+ channel

Indexed keywords

PHENYLEPHRINE; POTASSIUM CHLORIDE; TRYPTOPHAN; TRYPTOPHAN ETHYL ESTER; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA CONSTRICTION; ARTERY DILATATION; ARTERY MUSCLE; ARTERY RESISTANCE; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; HEART RATE; IN VITRO STUDY; IN VIVO STUDY; MALE; MEAN ARTERIAL PRESSURE; MESENTERIC ARTERY; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SMOOTH MUSCLE FIBER; STEADY STATE; THORACIC AORTA;

ANIMALS; AORTA; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; DOSE-RESPONSE RELATIONSHIP, DRUG; INHIBITORY CONCENTRATION 50; MALE; MESENTERIC ARTERIES; MUSCLE, SMOOTH, VASCULAR; PATCH-CLAMP TECHNIQUES; PHENYLEPHRINE; POTASSIUM CHLORIDE; RATS; RATS, SPRAGUE-DAWLEY; TRYPTOPHAN; VASODILATION;

EID: 84859704289     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01693.x     Document Type: Article

References (36)

1. Alexander SPH, Mathie A, Peters JA, (2011). Guide to Receptors and Channels (GRAC), 5th Edition. Br J Pharmacol 164 (Suppl. 1): S1-S324.
2. Allen T, Iftinca M, Cole WC, Plane F, (2002). Smooth muscle membrane potential modulates endothelium-dependent relaxation of rat basilar artery via myo-endothelial gap junctions. J Physiol 545: 975-986.
3. Cynober LA, (2002). Plasma amino acid levels with a note on membrane transport: characteristics, regulation, and metabolic significance. Nutrition 18: 761-766.
4. Desai KM, Gopalakrishnan V, Hiebert LM, McNeill JR, Wilson TW, (2006). EDHF-mediated rapid restoration of hypotensive response to acetylcholine after chronic, but not acute, nitric oxide synthase inhibition in rats. Eur J Pharmacol 546: 120-126.
5. Diaz J, Ni W, Thompson J, King A, Fink GD, Watts SW, (2008). 5-Hydroxytryptamine lowers blood pressure in normotensive and hypertensive rats. J Pharmacol Exp Ther 325: 1031-1038.
6. Erdmann K, Cheung BW, Schroder H, (2008). The possible role of food-derived bioactive peptides in reducing the risk of cardiovascular diseases. J Nutr Biochem 19: 643-654.
7. Feltkamp H, Meurer KA, Godchardt E, (1984). Tryptophan-induced lowering of blood pressure and changes of serotonin uptake by platelets in patients with essential hypertension. Klin Wochenschr 62: 1115-1119.
8. Fregly MJ, Sumners C, Cade JR, (1989). Effect of chronic dietary treatment with L-tryptophan on the maintenance of hypertension in spontaneously hypertensive rats. Can J Physiol Pharmacol 67: 656-662.
9. Hofmann F, (2010). Ido brings down the pressure in systemic inflammation. Nature Med 16: 265-267.
10. Hopfner RL, Hasnadka RV, Wilson TW, McNeill JR, Gopalakrishnan V, (1998). Insulin increases endothelin-1-evoked intracellular free calcium responses by increased ET(A) receptor expression in rat aortic smooth muscle cells. Diabetes 47: 937-944.
11. Kawabata A, Nakaya Y, Kuroda R, Wakisaka M, Masuko T, Nishikawa H, et al,. (2003). Involvement of EDHF in the hypotension and increased gastric mucosal blood flow caused by PAR-2 activation in rats. Br J Pharmacol 140: 247-254.
12. Knott PJ, Curzon G, (1972). Free tryptophan in plasma and brain tryptophan metabolism. Nature 239: 452-453.
13. Laight DW, Desai KM, Anggärd EE, Carrier MJ, (2000). Endothelial dysfunction accompanies a pro-oxidant, pro-diabetic challenge in the insulin resistant, obese Zucker rat in vivo. Eur J Pharmacol 402: 95-99.
14. Liang W, Ray JB, He JZ, Backx PH, Ward ME, (2009). Regulation of proliferation and membrane potential by chloride currents in rat pulmonary artery smooth muscle cells. Hypertension 54: 286-293.
15. Mishra RC, Tripathy S, Desai KM, Quest D, Lu Y, Akhtar J, et al,. (2008a). Nitiric oxide synthase inhibition promotes endothelium dependent vasodilation and antihypertensive effect of L-serine. Hypertension 51: 791-796.
16. Mishra RC, Tripathy S, Quest D, Desai KM, Akhtar J, Dattani ID, et al,. (2008b). L-Serine lowers while glycine increases blood pressure in chronic L-NAME-treated and spontaneously hypertensive rats. J Hypertens 26: 2339-2348.
17. Mishra RC, Tripathy S, Gandhi JD, Balsevich J, Akhtar J, Desai KM, et al,. (2010). Decrease in splanchnic vascular resistance contribute to hypotensive effects of L-serine in hypertensive rats. Am J Physiol Heart Circ Physiol 298: H1789-H1796.
18. Mulvany MJ, Halpern W, (1976). Mechanical properties of vascular smooth muscle cells in situ. Nature 260: 617-619.
19. Ni W, Geddes TJ, Priestley JR, Szasz T, Kuhn DM, Watts SW, (2008). The existence of a local 5-hydroxytryptaminergic system in peripheral arteries. Br J Pharmacol 154: 663-674.
20. Pop E, Anderson W, Prokai-Tatrai K, Brewster ME, Fregly M, Bodor N, (1990). Antihypertensive activity of redox derivatives of tryptophan. J Med Chem 33: 2216-2221.
21. Safdy ME, Kurchacova E, Schut RN, Vidrio H, Hong E, (1982). Tryptophan analogues. 1. Synthesis and antihypertensive activity of positional isomers. J Med Chem 25: 723-730.
22. Shinde UA, Desai KM, Yu C, Gopalakrishnan V, (2005). Nitric oxide synthase inhibition exaggerates the hypotensive response to ghrelin: role of calcium-activated potassium channels. J Hypertens 23: 779-784.
23. Sliskovic I, Abdulhamid I, Sharma M, Abu-Soud HM, (2009). Analysis of the mechanism by which tryptophan analogs inhibit human myeloperoxidase. Free Radic Biol Med 47: 1005-1013.
24. Stamler J, Brown IJ, Daviglus ML, Chan Q, Kesteloot H, Ueshima H, et al,. (2009). Glutamic acid, the main dietary amino acid, and blood pressure: the INTERMAP Study. Circulation 120: 221-228.
25. Sved AF, Van Itallie CM, Fernstrom JD, (1982). Studies on the antihypertensive action of L-tryptophan. J Pharmacol Exp Ther 221: 329-333.
26. Tanaka M, Tokuyasu M, Matsui T, Matsumoto K, (2008). Endothelium- independent vasodilation effect of di- and tri-peptides in thoracic aorta of Sprague-Dawley rats. Life Sci 82: 869-875.
27. Tanaka M, Watanabe S, Wang Z, Matsumoto K, Matsui T, (2009). His-Arg-Trp potently attenuates contracted tension of thoracic aorta of Sprague-Dawley rats through the suppression of extracellular Ca2+ influx. Peptides 30: 1502-1507.
28. 2+ channels in mesenteric veins: mechanism of venous smooth muscle resistance to calcium channel blockers. Circ Res 106: 739-747.
29. 2+ channels. Br J Pharmacol 162: 749-762.
30. Wang Y, Liu H, McKenzie G, Witting PK, Stasch JP, Hahn M, et al,. (2010a). Kynurenine is an endothelium-derived relaxing factor produced during inflammation. Nature Med 16: 279-287.
31. 2+ channels. Peptides 31: 2060-2066.
32. Watts SW, (2009). The love of a lifetime: 5-HT in the cardiovascular system. Am J Physiol Regul Integr Comp Physiol 296: R252-R256.
33. Wolf WA, Kuhn DM, (1984a). Effects of L-tryptophan on blood pressure in normotensive and hypertensive rats. J Pharmacol Exp Ther 230: 324-329.
34. Wolf WA, Kuhn DM, (1984b). Antihypertensive effects of L-tryptophan are not mediated by brain serotonin. Brain Res 295: 356-359.
35. Xu YJ, Arneja AS, Tappia PS, Dhalla NS, (2008). The potential health benefits of taurine in cardiovascular disease. Exp Clin Cardiol 13: 57-65.
36. Yamori Y, Liu L, Mori M, Sagara M, Murakami S, Nara Y, et al,. (2009). Taurine as the nutritional factor for the longevity of the Japanese revealed by a world-wide epidemiological survey. Adv Exp Med Biol 643: 13-25.